HM Payson & Co’s Elanco Animal Health ELAN Stock Holding History

HM Payson & Co’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-324	Closed	-$6K	–	1007
2022 Q2	$6K	Buy	+324	New	+$7.67K	﹤0.01%	871

Other funds holding ELAN

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

HM Payson & Co's ELAN Position: Q3 2022 in Review

HM Payson & Co sold out of Elanco Animal Health (ELAN) in Q3 2022, closing a stake of 324 shares — an estimated $6K sold.

HM Payson & Co first reported a position in ELAN in Q2 2022 and held it in 1 quarter. The position peaked at $6K in Q2 2022. 418 funds tracked by Wall St. Rank hold ELAN as of Q3 2022.

HM Payson & Co reported no remaining Elanco Animal Health position as of Q3 2022 after selling out during the quarter.
HM Payson & Co sold 324 Elanco Animal Health shares in Q3 2022, an estimated $6K.
HM Payson & Co first reported a position in Elanco Animal Health in Q2 2022 and held it in 1 quarter.
HM Payson & Co's Elanco Animal Health position peaked at $6K in Q2 2022.
418 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2022.

Based on HM Payson & Co's 13F filing for Q3 2022, filed 25 Oct 2022.